Translating Pre-Clinical Research to Clinical Patient Care™
MSACL 2020 USPalm Springs, Mar 29 - Apr 3 |
Details
MSACL US
MSACL 2020 US
Supporting Societies
MSACL 2020 US
Media Partners
Scientific Committee
The Scientific Committee is assembled to review abstract submissions for the annual conference. This includes reviewing abstract submissions, suggesting plenary speakers, recruiting researchers to solicit abstracts for submission to the conference and identifying emerging topics of interest. The topics outlined below are the dominant topics addressed the MSACL conferences. MSACL encourages submissions in all areas of clinical mass spectrometry and evaluates abstracts that do not fall in the main topical categories listed below.
Chair | |
 |
Daniel Holmes, MD, FRCPC Financial Disclosures (past 24 months as of Nov 15, 2024)
|
Vice Chair | |
 |
Cory Bystrom, PhD Financial Disclosures (past 24 months as of Feb 13, 2024)
|
Scientific Committee | |
Data Science | |
 |
Patrick Mathias, MD, PhD (Lead) Financial Disclosures (past 24 months as of Feb 13, 2024) : none |
 |
Shannon Haymond, PhD Financial Disclosures (past 24 months as of Feb 13, 2024) : none |
 |
Randall Julian, PhD Financial Disclosures (past 24 months as of Feb 13, 2024)
|
Imaging | |
 |
Peggi Angel, PhD (Lead) Financial Disclosures (past 24 months as of Feb 16, 2024)
|
 |
Livia Eberlin, PhD (Lead) Financial Disclosures (past 24 months as of Jan 06, 2024) : none |
 |
Christopher Anderton, PhD Financial Disclosures (past 24 months) : Not reported |
 |
Richard Drake, PhD Financial Disclosures (past 24 months) : Not reported |
 |
Kristine Glunde, Ph.D., M.S. Financial Disclosures (past 24 months) : Not reported |
 |
Reid GroseClose, PhD Financial Disclosures (past 24 months) : Not reported |
 |
Jeffrey Spraggins, PhD Financial Disclosures (past 24 months) : Not reported |
Metabolomics | |
 |
Adam Rosebrock, PhD (Lead) Financial Disclosures (past 24 months) : Not reported |
 |
Erin Baker, PhD Financial Disclosures (past 24 months) : Not reported |
Microbiology | |
 |
Chris Cox, PhD (Lead) Financial Disclosures (past 24 months) : Not reported |
 |
Clifton Fagerquist, PhD Financial Disclosures (past 24 months) : Not reported |
 |
Rebecca Harris, MD Financial Disclosures (past 24 months) : Not reported |
Practical Training | |
 |
Grace van der Gugten, B.Sc. Chemistry (Lead) Financial Disclosures (past 24 months as of Feb 13, 2024) : none |
 |
Deborah French, PhD, DABCC (CC, TC) Financial Disclosures (past 24 months as of Feb 12, 2024)
|
 |
Jacqueline Hubbard, PhD, DABCC Financial Disclosures (past 24 months as of Nov 11, 2024)
|
Proteomics | |
 |
Christopher Shuford, PhD (Lead) Financial Disclosures (past 24 months as of Feb 12, 2024)
|
 |
Timothy Collier, PhD Financial Disclosures (past 24 months as of Feb 12, 2024)
|
 |
Mari DeMarco, PhD, DABCC, FACB, FCACB Financial Disclosures (past 24 months) : Not reported |
 |
Andy Hoofnagle, MD, PhD Financial Disclosures (past 24 months as of Feb 13, 2024)
|
Tox / TDM / Endocrine | |
 |
Jennifer Colby, PhD (Lead) Financial Disclosures (past 24 months as of Feb 13, 2024)
|
 |
Marilyn Huestis, PhD Financial Disclosures (past 24 months) : Not reported |
 |
Hema Ketha, PhD Financial Disclosures (past 24 months) : Not reported |
 |
Mark Marzinke, PhD, DABCC, FAACC Financial Disclosures (past 24 months) : Not reported |
 |
Richard van Breemen, PhD Financial Disclosures (past 24 months) : Not reported |
Join the conversation